the importance of brca-1 testing in triple negative breast cancer
Published 6 months ago • 176 plays • Length 0:41Download video MP4
Download video MP3
Similar videos
-
1:48
residual tumor treatment in mutant brca-1 triple-negative breast cancer
-
0:57
treating brca1 and brca2 breast cancer
-
2:17
genetic testing in breast cancer: who, what and why?
-
4:24
the latest treatment options for brca-mutated breast cancer
-
0:43
management of residual disease in triple negative breast cancer
-
14:51
brca genetic testing: what to know & why its important
-
4:09
doctor explains brca1 & brca2 genetic testing for inherited breast and ovarian cancer...
-
35:40
understanding brca 1/2 cancer risk | dana-farber cancer institute
-
1:12
impact of genomic testing on treatment decision-making in breast cancer
-
6:25
economic evaluation of population-based brca testing
-
2:37
triple-negative breast cancer patients should undergo genetic screening - mayo clinic
-
8:37
brca1 and brca2 mutations & cancer (types of cancer, and who’s most at risk)
-
4:20
keynote-522: 5-year follow-up of pembrolizumab in triple-negative breast cancer
-
1:52
parpi for somatic brca1/2 and other dna repair gene mutations in women with metastatic breast cancer
-
31:24
breast cancer & genetic testing: ask dr. claudine isaacs
-
2:47
current treatment landscape of triple negative breast cancer
-
19:11
hereditary breast cancer genetics in 2019 - brittany bychkovsky, md, msc
-
5:29
implications for germline brca testing in breast cancer
-
3:39
zen-3694, a novel bet inhibitor, in tnbc without germline brca1/2 mutations